Discover
Share the concern, treatment area and change you would like to explore
Loading
Preparing the next part of your clinic journey.
Please wait while the page content is assembled.
Malaysia JB Certified Aesthetic Clinic in Eco Botanic
Lenisna PDLLA + HA Treatment in JB
LENISNA is an injectable product developed by VAIM Co., Ltd. combining 170 mg of Poly-D,L-Lactic Acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid (HA). It is positioned as a volume-focused biostimulator.
PROCEDUREFace/Skin
Treatment overview
CategoryProcedure
Treatment focusFace/Skin
PlanningPersonalised to your goals
Your visitGuided by our clinic team
AT A GLANCEA clear introduction to the treatment
What is Lenisna PDLLA + HA Treatment in JB?
LENISNA is an injectable product developed by VAIM Co., Ltd. combining 170 mg of Poly-D,L-Lactic Acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid (HA). It is positioned as a volume-focused biostimulator.
- Explore the concern you would like to address
- Understand how the treatment works
- Compare suitable treatment approaches
- Plan your visit and recovery
01 / How it works
Understanding the treatment approach
LENISNA is positioned as a hybrid biostimulator. It contains porous microspheres of PDLLA a biodegradable synthetic polymer suspended in a non-crosslinked HA carrier. Following injection, the HA component may provide early temporary hydration and fullness. Over time, the PDLLA particles create a controlled inflammatory tissue response intended to support fibroblast activity and gradual collagen-related tissue remodelling.
LENISNA is an injectable product developed by VAIM Co., Ltd. combining 170 mg of Poly-D,L-Lactic Acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid (HA). It is positioned as a volume-focused biostimulator.
Personalise
Shape the approach around your features, preferences and schedule
Treat
Experience a carefully planned session with clear guidance throughout
Support
Follow simple aftercare and review how the treatment is progressing
02 / Visual guide
A closer look at Lenisna PDLLA + HA Treatment in JB
LENISNA is an injectable product developed by VAIM Co., Ltd. combining 170 mg of Poly-D,L-Lactic Acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid (HA). It is positioned as a volume-focused biostimulator.
- Treatment focus
- Face/Skin
- Category
- Procedure
- Planning style
- Tailored to your goals and treatment area
Interactive treatment map
Explore Lenisna PDLLA + HA Treatment in JB step by step.
Tap a numbered point to move from your concern to the treatment approach, how it works and a personalised plan.
PROCEDURE · INTERACTIVE GUIDE
TAP 1–4 TO EXPLOREYour concern
Start with the change you have noticed and the result you would like to explore.
Facial areas
Concerns & areas
What this treatment may help address
Explore common areas and goals, then discuss which are most relevant to you.
Facial areas
Learn how this area can be approached within a personalised treatment plan.
Skin quality
Learn how this area can be approached within a personalised treatment plan.
Concern-specific areas
Learn how this area can be approached within a personalised treatment plan.
Personalised treatment areas
Learn how this area can be approached within a personalised treatment plan.
Who may benefit
People exploring face/skin with a personalised approach.
- You have a clear concern or treatment goal
- You would like to understand the available approaches
- You prefer a plan shaped around your features and schedule
- You value clear guidance before and after treatment
Anatomical Assessment: We assess your facial skeletal structure, fat compartments, skin laxity, and muscle activity. Volume loss in areas like the cheeks, temples (an anatomically advanced vascular area), and selected nasolabial folds or marionette areas often requires careful planning. We also assess selected atrophic acne scars, distinguishing between rolling, boxcar, or tethered scars which may require different interventions.
LENISNA is intended for selected adults with realistic expectations. We do not market this treatment to minors, nor do we perform it for creating a guaranteed V-shaped face, copying social media trends, or replacing a surgical facelift. Patients with active infections, unresolved nodules from previous injectables, autoimmune conditions, or those who are pregnant must delay treatment.
What to discuss first
Share anything that may shape your treatment experience.
- Current skin or health concerns
- Medicines, pregnancy or previous treatment
- Your preferred result and timing
- Questions about the product, device or recovery
03 / Your treatment journey
From first conversation to follow-up
A calm, well-explained experience at every stage.
- 01
Consultation
Talk through the concern, your previous experiences and the result you would like to explore.
- 02
Personalised planning
Review the treatment area, suitable options, expected experience and practical timing.
- 03
Treatment session
Arrive prepared and receive clear guidance throughout the treatment visit.
- 04
Aftercare & follow-up
Leave with simple aftercare, helpful contact details and a plan for review.
Helpful preparation and aftercare
Yes. Medi Clinic actively serves visitors travelling via the Causeway and Tuas Second Link for doctor-led assessments. We strongly encourage you to bring your previous injectable records and disclose any prior biostimulators or hyaluronidase treatments.
Exact-Product Verification: We must confirm current LENISNA or JUVELOOK Volume availability by verifying genuine sealed packaging, lot numbers, and exact Malaysia Medical Device Register (MDA) status from an authorised supplier. Overseas CE or Korean registrations do not automatically guarantee local intended-purpose approvals.
Treatment is never guaranteed on the same day. We do not sell fixed “vial packages” because session counts depend entirely on individual anatomical needs and tissue response. Our patients from Johor Bahru, Eko Galleria, and Singapore appreciate that we set realistic goals, explaining that LENISNA may support gradual facial-volume improvement, but permanent collagen or fat restoration cannot be guaranteed.
All facial injectables carry medical risks. Common temporary reactions include redness, swelling, bruising, tenderness, and firmness at the injection site. More importantly, because LENISNA contains PDLLA particles, delayed inflammatory reactions such as persistent nodules or granulomas can occur weeks or months later. A published case report has also documented a nodular reaction following JUVELOOK Volume use in the delicate tear-trough area, demonstrating that under-eye treatment is not risk-free.
04 / Practical expectations
Results, sessions, comfort and recovery
Your experience will reflect the selected treatment, treatment area and individual response. These are the useful details to explore during your visit.
- Visible change
- May be immediate or develop gradually
- Number of sessions
- Planned around your goals and response
- Comfort
- Explained for the treatment and area
- Recovery
- Clear guidance for common short-term effects
- Maintenance
- Reviewed as your results develop
- Other options
- Compare approaches with confidence
05 / Compare your options
Understand what makes Lenisna PDLLA + HA Treatment in JB different.
Compare the treatment approach, the area it is designed for, the experience and the way results may develop—not only the name or price.
Begins with a familiar name
A useful starting point when you already know the treatment and want to understand it more clearly.
Begins with the change you want
Opens a wider conversation about suitable approaches, timing, recovery and natural-looking results.
Treatment gallery
Lenisna PDLLA + HA Treatment in JB, explained visually.
Explore the consultation, treatment setting and preparation through a carefully selected visual story.
Related concerns
Explore the goals connected to Lenisna PDLLA + HA Treatment in JB
Begin with the concern you notice, then discover treatment approaches and questions worth bringing to your consultation.
Patient knowledge guide
How well do you understand Lenisna PDLLA + HA Treatment in JB?
Four short questions explain the treatment, suitability and why assessment matters. This quiz educates—it does not diagnose or confirm treatment eligibility.
Question 1 / 4
What should be confirmed about Lenisna PDLLA + HA Treatment in JB?
06 / Before you decide
Important considerations
Each treatment has its own considerations. Your consultation is the place to discuss expected benefits, possible side effects, alternatives and anything that may affect timing.
Read about informed consent07 / Recovery
Aftercare made clear
All facial injectables carry medical risks. Common temporary reactions include redness, swelling, bruising, tenderness, and firmness at the injection site. More importantly, because LENISNA contains PDLLA particles, delayed inflammatory reactions such as persistent nodules or granulomas can occur weeks or months later. A published case report has also documented a nodular reaction following JUVELOOK Volume use in the delicate tear-trough area, demonstrating that under-eye treatment is not risk-free.
Contact the clinic08 / FAQ
Frequently asked questions about Lenisna PDLLA + HA Treatment in JB
Helpful answers for planning your consultation and understanding the treatment experience.
How LENISNA & JUVELOOK Volume Work
LENISNA is positioned as a hybrid biostimulator. It contains porous microspheres of PDLLA a biodegradable synthetic polymer suspended in a non-crosslinked HA carrier. Following injection, the HA component may provide early temporary hydration and fullness. Over time, the PDLLA particles create a controlled inflammatory tissue response intended to support fibroblast activity and gradual collagen-related tissue remodelling.
What is LENISNA?
LENISNA is an injectable product developed by VAIM Co., Ltd. combining 170 mg of Poly-D,L-Lactic Acid (PDLLA) and 30 mg of non-crosslinked hyaluronic acid (HA). It is positioned as a volume-focused biostimulator.
Is LENISNA the same as standard JUVELOOK?
No. Standard JUVELOOK is a lower-content formulation containing 42.5 mg PDLLA and 7.5 mg HA, generally used for superficial skin concerns. They do not share the same treatment areas, protocols, or evidence.
Is LENISNA the same as JUVELOOK Volume?
According to current VAIM information, LENISNA and JUVELOOK Volume are two names for the same 170 mg PDLLA formulation used in different markets. However, the exact Malaysian registration must always be verified before treatment.
Is LENISNA the same as Sculptra or AestheFill?
No. Sculptra contains PLLA (Poly-L-Lactic Acid) and AestheFill is a separate PDLLA product from a different manufacturer. Each product has unique particle characteristics, clinical evidence, and preparation methods.
Is LENISNA fully reversible?
No. While the enzyme hyaluronidase can affect the non-crosslinked HA carrier, it does not dissolve the PDLLA particles. A complete return to your original appearance cannot be guaranteed, making precise doctor placement essential.
Related treatments
Compare other approaches
Plan your next step
Would you like to explore Lenisna PDLLA + HA Treatment in JB?
Share your goals with the Eco Botanic team and begin with a personalised consultation.